Pharma Execs Dig In For A Fight Against Outraged Senators
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
The independent source for health policy research, polling, and news.
6,261 - 6,280 of 15,457 Results
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
New Mexico is one of several states looking at offering consumers a government-sponsored plan. The proposals would typically have benefits similar to what is available in Medicaid, the state-federal health plan for low-income people.
The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
Kim Nelson started the group South Carolina Parents for Vaccines after learning that religious exemptions from vaccine requirements were way up in her community.
The new regulation would drop previous rules for the Title X program requiring that women with unintended pregnancies be told about all options, including abortion. It would also mandate that organizations separate facilities providing federally funded services from those providing abortions.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Tuesday’s Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
California’s highly touted gains in vaccinating schoolchildren against measles stalled last year, possibly related to an increase in the number of students who have been exempted from vaccinations on medical grounds.
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
The Centers for Medicare & Medicaid Services launched this month the “What’s Covered” app, designed to provide yes-or-no answers about what services are covered under traditional Medicare. KHN took it for a test drive with real consumers.
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
Inspired by Los Angeles teachers, who were promised 300 more school nurses after striking last month, unions in Denver, Oakland, Calif., and beyond are demanding more school nurses or better compensation for them.
Health officials and doctors treating patients with HIV welcome the funding push, but warn that the strategies that work in progressive cities don't necessarily translate to rural areas.
In an emerging new tactic against the rising toll of opioid deaths, California, Ohio, Virginia and Arizona are among the states requiring physicians to offer patients naloxone when they give them prescriptions for the powerful painkillers. The Food and Drug Administration is weighing a national recommendation to do so.
For dozens of hours each week, Dawn Wilcox scours the internet for news stories of women killed by men for a public list called Women Count USA.
Support for “Medicare-for-all” is becoming a front-runner topic among Democratic presidential candidates. But the phrase is being used to describe any number of policies.
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue that’s not medically necessary to pay for.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
© 2026 KFF